Pooled analysis of LUOSICNS and OUTRUN trials highlighted by Prof Wang Lin from the Cancer Hospital of The Chinese Academy of Medical Sciences at the National Cancer Centre Forum on Translational Oncology & International Symposium on Progress in Lung Cancer Research (INSPIRE).
Latest posts 5
Why do the TheraP and VISION trials show different effects of Lu-177 PSMA on survival in advanced prostate cancer? It may be due to different comparison treatments.
jamanetwork.com/journals/jaman…
@MartinStockler @IanMarschner @DrMHofman @Prof_IanD @drlouiseemmett
jamanetwork.com/journals/jaman…
@MartinStockler @IanMarschner @DrMHofman @Prof_IanD @drlouiseemmett
Why do treatment effects reported in interim analyses of clinical trials often diminish later? Overestimation bias, non-proportional hazards, and recruitment heterogeneity can contribute. @MartinStockler @IanMarschner @ChrisSweens1 @Prof_IanD sciencedirect.com/science/articl…
Improved health related quality of life with comprehensive geriatric assessment guided care are more likely to be reported by RCTs with larger sample size or those using CGA before initiating anti cancer treatments. @MartinStockler @drprunellab
sciencedirect.com/science/articl…
sciencedirect.com/science/articl…
Finally published ! @TC30382220 @little_blackbk
Stroke Risks in Survivors of Head and Neck Cancer jamanetwork.com/journals/jaman…
Stroke Risks in Survivors of Head and Neck Cancer jamanetwork.com/journals/jaman…